title: New potential therapeutic approaches in frontotemporal dementia: oxytocin, vasopressin, and social cognition.
abstract: Frontotemporal dementias are neurodegenerative disorders marked by mid-life onset and progressive changes in behavior, decision making, and/or language. In several subtypes of frontotemporal dementia (FTD), damage to regions of the frontal and temporal lobes that occurs early in the disease course critically impairs emotional processing, social cognition, and behavior. To date, there are no curative or disease-modifying treatments for FTD, nor any approved treatments for the loss of empathy, impaired social cognition, and behavior of patients with FTD. A growing body of research suggests that the neuropeptides oxytocin and vasopressin are important mediators of social behavior in humans and other animals. Here, we review the effects of oxytocin and vasopressin on social cognition and behavior and discuss the potential implications for these agents as novel treatments in FTD.
authors: Department of Clinical Neurological Sciences, Schulich School of Medicine, University of Western Ontario, B10-004, 339 Windermere Rd, London, ON, N6A 5A5, Canada. Elizabeth.Finger@lhsc.on.ca
authors: Elizabeth C
authors: EC
authors: Finger
references: J Clin Psychiatry. 2008 Dec;69(12):1981-2
references: 19203481
references: J Psychopharmacol. 2009 May;23(3):241-8
references: 18801829
references: Curr Opin Neurobiol. 2010 Dec;20(6):784-94
references: 20850965
references: Neuroscience. 2005;133(3):635-46
references: 15908133
references: Physiol Behav. 1995 Apr;57(4):615-27
references: 7777594
references: Physiol Rev. 2001 Apr;81(2):629-83
references: 11274341
references: Science. 2010 Jun 11;328(5984):1408-11
references: 20538951
references: J Neurosci. 1994 Sep;14(9):5381-92
references: 8083743
references: Biol Psychiatry. 2008 Jan 1;63(1):3-5
references: 17888410
references: Ann N Y Acad Sci. 2009 Jun;1167:87-102
references: 19580556
references: Neuron. 2008 May 22;58(4):639-50
references: 18498743
references: Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12736-41
references: 11606726
references: Arch Gen Psychiatry. 1998 Aug;55(8):708-14
references: 9707381
references: J Comp Neurol. 1999 Aug 23;411(2):181-200
references: 10404247
references: Peptides. 2004 Sep;25(9):1565-74
references: 15374658
references: Physiol Behav. 1988;44(2):235-9
references: 2853382
references: Biol Psychiatry. 2007 Feb 15;61(4):498-503
references: 16904652
references: Brain Res. 1983 Aug 29;273(2):307-17
references: 6311351
references: Neuropsychopharmacology. 2010 Dec;35(13):2502-9
references: 20844475
references: Proc Natl Acad Sci U S A. 2009 Nov 10;106(45):19144-9
references: 19858480
references: Neuron. 2010 Mar 25;65(6):768-79
references: 20346754
references: Psychoneuroendocrinology. 2011 Feb;36(2):294-7
references: 20729000
references: Psychoneuroendocrinology. 2010 Jan;35(1):83-93
references: 19632787
references: Brain. 2002 Apr;125(Pt 4):752-64
references: 11912109
references: Physiol Behav. 2005 Jun 30;85(3):354-62
references: 15935410
references: Neuropsychopharmacology. 2003 Jan;28(1):193-8
references: 12496956
references: Biol Psychiatry. 2007 Nov 15;62(10):1187-90
references: 17617382
references: Neuropsychologia. 2005;43(11):1673-87
references: 16009249
references: J Neurosci. 2010 Apr 7;30(14):4999-5007
references: 20371820
references: Biol Psychiatry. 2007 Mar 15;61(6):731-3
references: 17137561
references: Front Neuroendocrinol. 2002 Apr;23(2):200-24
references: 11950245
references: Soc Cogn Affect Neurosci. 2008 Jun;3(2):128-34
references: 19015103
references: Int J Geriatr Psychiatry. 2005 Nov;20(11):1028-37
references: 16250064
references: Science. 2008 Nov 7;322(5903):900-4
references: 18988842
references: Eur J Neurosci. 2010 Mar;31(5):883-91
references: 20374286
references: Neurology. 2006 Jan 10;66(1):17-22
references: 16401839
references: Ann Neurol. 2005 Feb;57(2):216-25
references: 15668960
references: Neuropsychologia. 2002;40(6):655-65
references: 11792405
references: Biol Psychiatry. 2010 Jun 15;67(12):1220-2
references: 20447617
references: Front Neuroendocrinol. 2004 Sep-Dec;25(3-4):132-49
references: 15589266
references: Brain Res Brain Res Rev. 2001 Jul;35(3):246-65
references: 11423156